Researchers develop vaccine for allergic diseases in animals
Zurich – Scientists at the universities of Zurich and Bern have developed a new vaccine that can help treat allergic diseases in dogs and horses. The findings could lead to similar therapeutic vaccines for humans.
New antibodies to combat the flu
Zurich – Together with scientists from the USA, researchers from the University of Zurich have discovered a new way in which certain antibodies interact with the flu virus. These findings could help in developing more efficient medication and vaccines.
Swisscom Blockchain joins forces with Digipharm
Zug – Swisscom Blockchain and Digipharm are working together to develop blockchain-based platforms for healthcare. Their shared aim is to bring about fair pricing and personalised therapy.
Hong Kong bitcoin exchange plans move to Switzerland
Zurich – One of the largest cryptocurrency exchanges in the world wants to relocate its headquarters to Switzerland, a move that will make Bitfinex the most transparent stock exchange of them all. Switzerland hopes for a knock-off effect for the crypto-scene.
Kickstart Accelerator opens third edition
Zurich – Kickstart Accelerator has launched the third edition of its programme in Zurich. Switzerland’s largest innovation acceleration programme, it initiates successful partnerships between startups, established companies and institutions.
Physicists build a more affordable brain scanner
Zurich – Two scientists at the Federal Institute of Technology in Zurich are building a brain scanner that is considerably less expensive and smaller than current models. The two have now earned a place in the “30 Under 30” list published by the U.S. business magazine Forbes.
Researchers speed up search for drugs
Zurich – Researchers at the Swiss Federal Institute of Technology in Zurich have developed a method for examining drug candidates. This makes the search for drugs cheaper and more efficient.
Students develop therapy device for skin disease
Zurich – Students from the Greater Zurich Area have developed a therapy device for the treatment of the skin infection leishmaniasis. It can be manufactured cheaply and could be used in developing countries, in particular.
LSZ Impact – Translational Medicine in Zurich
Meet with an expansion expert
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space